Delivery of Antisense Oligodeoxynucleotide as Inhibitor of 5-Hydroxytryptamine Reuptake*

Author： Miller K.J. Chattaraj S.C. Das S.K.

ISSN： 1460-8081

Source： Pharmacy and Pharmacology Communications, Vol.5, Iss.11, 1999-11, pp. : 631-634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine

By Hajos-Korcsok

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT 1B/1D receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat

By Mitchell S.N. Greenslade R.G. Cooper J.

European Journal of Pharmacology, Vol. 432, Iss. 1, 2001-11 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine 2A receptor antagonist: a comparison with the antidepressant, nefazodone

By Pullar I.A. Carney S.L. Colvin E.M. Lucaites V.L. Nelson D.L. Wedley S.

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

By Haddjeri N. De Montigny C. Curet O. Blier P.

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 179-192

Elsevier

Access to resources Recommend Favorite

Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT 1A receptor antagonist on 5-hydroxytryptamine cell firing and release

By Sharp T. Gartside S.E. Umbers V.

European Journal of Pharmacology, Vol. 320, Iss. 1, 1997-02 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite